Screener
Spyre Therapeutics, Inc. SYRE Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Spyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The source filing: Spyre Therapeutics, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 8:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001636282-26-000050
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Proceeds from issuance of common stock in connection with at-the-market offering program, net of issuance costs | 9,750 | — |
| Payment of deferred offering costs in connection with shelf registration | (171) | (93) |
| Proceeds from employee stock option exercises and employee stock plan purchases | 2,676 | 218 |
| Net cash provided by financing activities | 12,255 | 125 |
| NET DECREASE IN CASH AND CASH EQUIVALENTS | 11,464 | (40,930) |
| CASH AND CASH EQUIVALENTS | ||
| Beginning of period | 85,721 | 89,423 |
| End of period | $97,185 | $48,493 |
Item 1. Financial Statements (Unaudited).
FAQ
- What is Spyre Therapeutics, Inc.'s financing cash flow?
- Spyre Therapeutics, Inc. (SYRE) reported financing cash flow of $12.26M in Q1 2026.
- How has Spyre Therapeutics, Inc.'s financing cash flow changed year-over-year?
- Spyre Therapeutics, Inc.'s financing cash flow increased by 9704.0% year-over-year, from $125K to $12.26M.
- What is the long-term trend for Spyre Therapeutics, Inc.'s financing cash flow?
- Over 2 years (2023 to 2025), Spyre Therapeutics, Inc.'s financing cash flow has grown at a -9.1% compound annual growth rate (CAGR), from $373.61M to $309.03M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.
Ask your AI about Spyre Therapeutics, Inc.'s financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude